Key result
Right ventricular systolic dysfunction was an independent predictor of increased all-cause mortality compared to normal RV function in patients with HFrEF.
Why the study?
While RVSD is an important determinant of heart failure outcomes and challenging to assess by 2D-echocardiography, the prognostic value of CMR-derived RV systolic function in HFrEF needed investigation.
Does CMR-derived right ventricular systolic dysfunction predict all-cause mortality in patients with HFrEF?
Observational (n=2,449)
Yes
Does CMR-derived right ventricular systolic dysfunction predict all-cause mortality in patients with HFrEF?
Answers are grounded in this paper and cite their sources.
CMR-derived right ventricular systolic dysfunction is an independent predictor of all-cause mortality in patients with HFrEF, particularly in early stages of HF progression.
AIMS: Right ventricular systolic dysfunction (RVSD) is an important determinant of outcomes in heart failure (HF) cohorts. While the quantitative assessment of RV function is challenging using 2D-echocardiography, cardiac magnetic resonance (CMR) is the gold standard with its high spatial resolution and precise anatomical definition. We sought to investigate the prognostic value of CMR-derived RV systolic function in a large cohort of HF with reduced ejection fraction (HFrEF). METHODS AND RESULTS: Study cohort comprised of patients enrolled in the CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DefibrillAtor ThErapy registry who had HFrEF and had simultaneous baseline CMR and echocardiography (n = 2449). RVSD was defined as RV ejection fraction (RVEF) <45%. Kaplan-Meier curves and cox regression were used to investigate the association between RVSD and all-cause mortality (ACM). Mean age was 59.8 ± 14.0 years, 42.0% were female, and mean left ventricular ejection fraction (LVEF) was 34.0 ± 10.8. Median follow-up was 959 days (interquartile range: 560-1590). RVSD was present in 936 (38.2%) and was an independent predictor of ACM (adjusted hazard ratio = 1.44; 95% CI [1.09-1.91]; P = 0.01). On subgroup analyses, the prognostic value of RVSD was more pronounced in NYHA I/II than in NYHA III/IV, in LVEF <35% than in LVEF ≥35%, and in patients with renal dysfunction when compared to those with normal renal function. CONCLUSION: RV systolic dysfunction is an independent predictor of ACM in HFrEF, with a more pronounced prognostic value in select subgroups, likely reflecting the importance of RVSD in the early stages of HF progression.
No takes yet. Share an insight, caveat, or question.
Al’Aref et al. (2022) conducted an observational in Heart failure with reduced ejection fraction (HFrEF) (n=2,449). Right ventricular systolic dysfunction (RVEF <45% by CMR) vs. Normal RV systolic function (RVEF ≥45%) was evaluated on All-cause mortality (aHR 1.44, 95% CI 1.09-1.91, p=0.01). Right ventricular systolic dysfunction was an independent predictor of increased all-cause mortality compared to normal RV function in patients with HFrEF.
Synapse has enriched 10 related papers. Consider them for comparative context: